EGFR and cancer: This concept is supported by alterations in the ability of cancer cells to migrate and proliferate due to derailed RTK trafficking (Mellman & Yarden, 2013; Lanzetti & Di Fiore, 2017) and by EGFR/integrin recycling‐dependent regulation of cancer cell migration (Caswell & Norman, 2008).